<?xml version='1.0' encoding='utf-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2023-06-28" version="267">
<accession>P04406</accession>
<accession>E7EUT4</accession>
<accession>P00354</accession>
<accession>Q53X65</accession>
<name>G3P_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="29">Glyceraldehyde-3-phosphate dehydrogenase</fullName>
<shortName evidence="28">GAPDH</shortName>
<ecNumber evidence="25">1.2.1.12</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="30">Peptidyl-cysteine S-nitrosylase GAPDH</fullName>
<ecNumber evidence="1">2.6.99.-</ecNumber>
</alternativeName>
</protein>
<gene>
<name evidence="28 36" type="primary">GAPDH</name>
<name evidence="29" type="synonym">GAPD</name>
<name type="ORF">CDABP0047</name>
<name type="ORF">OK/SW-cl.12</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="EMBO J." volume="3" first="2627" last="2633">
<title>
The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse.
</title>
<authorList>
<person name="Hanauer A."/>
<person name="Mandel J.-L."/>
</authorList>
<dbReference type="PubMed" id="6096136"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1984.tb02185.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1984" name="Nucleic Acids Res." volume="12" first="9179" last="9189">
<title>
The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species.
</title>
<authorList>
<person name="Arcari P."/>
<person name="Martinelli R."/>
<person name="Salvatore F."/>
</authorList>
<dbReference type="PubMed" id="6096821"/>
<dbReference type="DOI" id="10.1093/nar/12.23.9179"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1985" name="Nucleic Acids Res." volume="13" first="2485" last="2502">
<title>
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.
</title>
<authorList>
<person name="Tso J.Y."/>
<person name="Sun X.-H."/>
<person name="Kao T.-H."/>
<person name="Reece K.S."/>
<person name="Wu R."/>
</authorList>
<dbReference type="PubMed" id="2987855"/>
<dbReference type="DOI" id="10.1093/nar/13.7.2485"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1987" name="Cancer Res." volume="47" first="5616" last="5619">
<title>
Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.
</title>
<authorList>
<person name="Tokunaga K."/>
<person name="Nakamura Y."/>
<person name="Sakata K."/>
<person name="Fujimori K."/>
<person name="Ohkubo M."/>
<person name="Sawada K."/>
<person name="Sakiyama S."/>
</authorList>
<dbReference type="PubMed" id="3664468"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="649" last="653">
<title>
Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Allen R.W."/>
<person name="Trach K.A."/>
<person name="Hoch J.A."/>
</authorList>
<dbReference type="PubMed" id="3027061"/>
<dbReference type="DOI" id="10.1016/s0021-9258(19)75833-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="15335" last="15341">
<title>
Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene.
</title>
<authorList>
<person name="Ercolani L."/>
<person name="Florence B."/>
<person name="Denaro M."/>
<person name="Alexander M."/>
</authorList>
<dbReference type="PubMed" id="3170585"/>
<dbReference type="DOI" id="10.1016/s0021-9258(19)37593-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="8460" last="8464">
<title>
A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Meyer-Siegler K."/>
<person name="Mauro D.J."/>
<person name="Seal G."/>
<person name="Wurzer J."/>
<person name="Deriel J.K."/>
<person name="Sirover M.A."/>
</authorList>
<dbReference type="PubMed" id="1924305"/>
<dbReference type="DOI" id="10.1073/pnas.88.19.8460"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="275" first="223" last="227">
<title>
cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs.
</title>
<authorList>
<person name="Ye Z."/>
<person name="Connor J.R."/>
</authorList>
<dbReference type="PubMed" id="10944468"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3282"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Astrocytoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<title>Pediatric leukemia cDNA sequencing project.</title>
<authorList>
<person name="Zhou J."/>
<person name="Yu W."/>
<person name="Tang H."/>
<person name="Mei G."/>
<person name="Tsang Y.T.M."/>
<person name="Bouck J."/>
<person name="Gibbs R.A."/>
<person name="Margolin J.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2001-05" db="EMBL/GenBank/DDBJ databases">
<title>
Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients.
</title>
<authorList>
<person name="Shichijo S."/>
<person name="Itoh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>
Cloning of human full-length CDSs in BD Creator(TM) system donor vector.
</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="12">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT GLY-22</scope>
</reference>
<reference key="13">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>
Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).
</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
<title>The finished DNA sequence of human chromosome 12.</title>
<authorList>
<person name="Scherer S.E."/>
<person name="Muzny D.M."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Montgomery K.T."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Lovering R.C."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Draper H."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Havlak P."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Li L."/>
<person name="Li Z."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Plopper F.J.H."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Allen C.C."/>
<person name="Amin A.G."/>
<person name="Anyalebechi V."/>
<person name="Bailey M."/>
<person name="Barbaria J.A."/>
<person name="Bimage K.E."/>
<person name="Bryant N.P."/>
<person name="Burch P.E."/>
<person name="Burkett C.E."/>
<person name="Burrell K.L."/>
<person name="Calderon E."/>
<person name="Cardenas V."/>
<person name="Carter K."/>
<person name="Casias K."/>
<person name="Cavazos I."/>
<person name="Cavazos S.R."/>
<person name="Ceasar H."/>
<person name="Chacko J."/>
<person name="Chan S.N."/>
<person name="Chavez D."/>
<person name="Christopoulos C."/>
<person name="Chu J."/>
<person name="Cockrell R."/>
<person name="Cox C.D."/>
<person name="Dang M."/>
<person name="Dathorne S.R."/>
<person name="David R."/>
<person name="Davis C.M."/>
<person name="Davy-Carroll L."/>
<person name="Deshazo D.R."/>
<person name="Donlin J.E."/>
<person name="D'Souza L."/>
<person name="Eaves K.A."/>
<person name="Egan A."/>
<person name="Emery-Cohen A.J."/>
<person name="Escotto M."/>
<person name="Flagg N."/>
<person name="Forbes L.D."/>
<person name="Gabisi A.M."/>
<person name="Garza M."/>
<person name="Hamilton C."/>
<person name="Henderson N."/>
<person name="Hernandez O."/>
<person name="Hines S."/>
<person name="Hogues M.E."/>
<person name="Huang M."/>
<person name="Idlebird D.G."/>
<person name="Johnson R."/>
<person name="Jolivet A."/>
<person name="Jones S."/>
<person name="Kagan R."/>
<person name="King L.M."/>
<person name="Leal B."/>
<person name="Lebow H."/>
<person name="Lee S."/>
<person name="LeVan J.M."/>
<person name="Lewis L.C."/>
<person name="London P."/>
<person name="Lorensuhewa L.M."/>
<person name="Loulseged H."/>
<person name="Lovett D.A."/>
<person name="Lucier A."/>
<person name="Lucier R.L."/>
<person name="Ma J."/>
<person name="Madu R.C."/>
<person name="Mapua P."/>
<person name="Martindale A.D."/>
<person name="Martinez E."/>
<person name="Massey E."/>
<person name="Mawhiney S."/>
<person name="Meador M.G."/>
<person name="Mendez S."/>
<person name="Mercado C."/>
<person name="Mercado I.C."/>
<person name="Merritt C.E."/>
<person name="Miner Z.L."/>
<person name="Minja E."/>
<person name="Mitchell T."/>
<person name="Mohabbat F."/>
<person name="Mohabbat K."/>
<person name="Montgomery B."/>
<person name="Moore N."/>
<person name="Morris S."/>
<person name="Munidasa M."/>
<person name="Ngo R.N."/>
<person name="Nguyen N.B."/>
<person name="Nickerson E."/>
<person name="Nwaokelemeh O.O."/>
<person name="Nwokenkwo S."/>
<person name="Obregon M."/>
<person name="Oguh M."/>
<person name="Oragunye N."/>
<person name="Oviedo R.J."/>
<person name="Parish B.J."/>
<person name="Parker D.N."/>
<person name="Parrish J."/>
<person name="Parks K.L."/>
<person name="Paul H.A."/>
<person name="Payton B.A."/>
<person name="Perez A."/>
<person name="Perrin W."/>
<person name="Pickens A."/>
<person name="Primus E.L."/>
<person name="Pu L.-L."/>
<person name="Puazo M."/>
<person name="Quiles M.M."/>
<person name="Quiroz J.B."/>
<person name="Rabata D."/>
<person name="Reeves K."/>
<person name="Ruiz S.J."/>
<person name="Shao H."/>
<person name="Sisson I."/>
<person name="Sonaike T."/>
<person name="Sorelle R.P."/>
<person name="Sutton A.E."/>
<person name="Svatek A.F."/>
<person name="Svetz L.A."/>
<person name="Tamerisa K.S."/>
<person name="Taylor T.R."/>
<person name="Teague B."/>
<person name="Thomas N."/>
<person name="Thorn R.D."/>
<person name="Trejos Z.Y."/>
<person name="Trevino B.K."/>
<person name="Ukegbu O.N."/>
<person name="Urban J.B."/>
<person name="Vasquez L.I."/>
<person name="Vera V.A."/>
<person name="Villasana D.M."/>
<person name="Wang L."/>
<person name="Ward-Moore S."/>
<person name="Warren J.T."/>
<person name="Wei X."/>
<person name="White F."/>
<person name="Williamson A.L."/>
<person name="Wleczyk R."/>
<person name="Wooden H.S."/>
<person name="Wooden S.H."/>
<person name="Yen J."/>
<person name="Yoon L."/>
<person name="Yoon V."/>
<person name="Zorrilla S.E."/>
<person name="Nelson D."/>
<person name="Kucherlapati R."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16541075"/>
<dbReference type="DOI" id="10.1038/nature04569"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="15">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
<tissue>Kidney</tissue>
<tissue>Lung</tissue>
<tissue>Lymph</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1981" name="FEBS Lett." volume="134" first="143" last="146">
<title>
The complete amino acid sequence of human muscle glyceraldehyde 3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Nowak K."/>
<person name="Wolny M."/>
<person name="Banas T."/>
</authorList>
<dbReference type="PubMed" id="7030790"/>
<dbReference type="DOI" id="10.1016/0014-5793(81)80587-x"/>
</citation>
<scope>PRELIMINARY PROTEIN SEQUENCE OF 2-335</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="566" last="569">
<title>
Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.
</title>
<authorList>
<person name="Gevaert K."/>
<person name="Goethals M."/>
<person name="Martens L."/>
<person name="Van Damme J."/>
<person name="Staes A."/>
<person name="Thomas G.R."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="12665801"/>
<dbReference type="DOI" id="10.1038/nbt810"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-13</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="19">
<citation type="submission" date="2009-07" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Gao M."/>
<person name="Leug H."/>
</authorList>
</citation>
<scope>
PROTEIN SEQUENCE OF 2-13; 62-84; 118-139; 198-215; 220-227; 235-248 AND 310-335
</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>
PROTEIN SEQUENCE OF 67-80; 87-107; 119-139; 146-186; 201-215; 235-248 AND 310-334
</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="1995" name="Electrophoresis" volume="16" first="1160" last="1169">
<title>
The major protein expression profile and two-dimensional protein database of human heart.
</title>
<authorList>
<person name="Kovalyov L.I."/>
<person name="Shishkin S.S."/>
<person name="Efimochkin A.S."/>
<person name="Kovalyova M.A."/>
<person name="Ershova E.S."/>
<person name="Egorov T.A."/>
<person name="Musalyamov A.K."/>
</authorList>
<dbReference type="PubMed" id="7498159"/>
<dbReference type="DOI" id="10.1002/elps.11501601192"/>
</citation>
<scope>PROTEIN SEQUENCE OF 220-226 AND 242-246</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="1975" name="Hoppe-Seyler's Z. Physiol. Chem." volume="356" first="1181" last="1183">
<title>
The covalent structure of glyceraldehyde-phosphate dehydrogenase from human muscles. Isolation and amino acid sequences of peptides from tryptic digest.
</title>
<authorList>
<person name="Nowak K."/>
<person name="Kuczek M."/>
<person name="Ostropolska L."/>
<person name="Malarska A."/>
<person name="Wolny M."/>
<person name="Branowski T."/>
</authorList>
<dbReference type="PubMed" id="1193541"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="3334" last="3341">
<title>
Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway.
</title>
<authorList>
<person name="Tisdale E.J."/>
</authorList>
<dbReference type="PubMed" id="11724794"/>
<dbReference type="DOI" id="10.1074/jbc.m109744200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PRKCI</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Biochim. Biophys. Acta" volume="1622" first="50" last="56">
<title>
Subcellular localization of human glyceraldehyde-3-phosphate dehydrogenase is independent of its glycolytic function.
</title>
<authorList>
<person name="Mazzola J.L."/>
<person name="Sirover M.A."/>
</authorList>
<dbReference type="PubMed" id="12829261"/>
<dbReference type="DOI" id="10.1016/s0304-4165(03)00117-x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>
Proteomic characterization of the human centrosome by protein correlation profiling.
</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Cell" volume="119" first="195" last="208">
<title>
Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation.
</title>
<authorList>
<person name="Sampath P."/>
<person name="Mazumder B."/>
<person name="Seshadri V."/>
<person name="Gerber C.A."/>
<person name="Chavatte L."/>
<person name="Kinter M."/>
<person name="Ting S.M."/>
<person name="Dignam J.D."/>
<person name="Kim S."/>
<person name="Driscoll D.M."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="15479637"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.09.030"/>
</citation>
<scope>IDENTIFICATION IN THE GAIT COMPLEX</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="225" last="232">
<title>
Oxidative stress-responsive intracellular regulation specific for the angiostatic form of human tryptophanyl-tRNA synthetase.
</title>
<authorList>
<person name="Wakasugi K."/>
<person name="Nakano T."/>
<person name="Morishima I."/>
</authorList>
<dbReference type="PubMed" id="15628863"/>
<dbReference type="DOI" id="10.1021/bi048313k"/>
</citation>
<scope>INTERACTION WITH WARS1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-42</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Cell. Mol. Life Sci." volume="63" first="723" last="734">
<title>
The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins.
</title>
<authorList>
<person name="Bosch-Comas A."/>
<person name="Lindsten K."/>
<person name="Gonzalez-Duarte R."/>
<person name="Masucci M.G."/>
<person name="Marfany G."/>
</authorList>
<dbReference type="PubMed" id="16501887"/>
<dbReference type="DOI" id="10.1007/s00018-005-5533-1"/>
</citation>
<scope>INTERACTION WITH USP25</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10735" last="10740">
<title>
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.
</title>
<authorList>
<person name="Wong J.J."/>
<person name="Pung Y.F."/>
<person name="Sze N.S."/>
<person name="Chin K.C."/>
</authorList>
<dbReference type="PubMed" id="16815975"/>
<dbReference type="DOI" id="10.1073/pnas.0600397103"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="587" last="602">
<title>
Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Seo J."/>
<person name="Jeong J."/>
<person name="Kim Y.M."/>
<person name="Hwang N."/>
<person name="Paek E."/>
<person name="Lee K.-J."/>
</authorList>
<dbReference type="PubMed" id="18183946"/>
<dbReference type="DOI" id="10.1021/pr700657y"/>
</citation>
<scope>
PHOSPHORYLATION AT THR-75; SER-122; SER-148; THR-229; THR-237 AND SER-312
</scope>
<scope>
DEAMIDATION AT ASN-9; ASN-64; ASN-70; ASN-149; ASN-155; ASN-225 AND ASN-316
</scope>
<scope>
METHYLATION AT LYS-5; LYS-66; LYS-194; LYS-215; LYS-227; LYS-260; LYS-263 AND LYS-334
</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-151 AND THR-184
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>
Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="766" last="773">
<title>
FKBP36 is an inherent multifunctional glyceraldehyde-3-phosphate dehydrogenase inhibitor.
</title>
<authorList>
<person name="Jarczowski F."/>
<person name="Jahreis G."/>
<person name="Erdmann F."/>
<person name="Schierhorn A."/>
<person name="Fischer G."/>
<person name="Edlich F."/>
</authorList>
<dbReference type="PubMed" id="19001379"/>
<dbReference type="DOI" id="10.1074/jbc.m709779200"/>
</citation>
<scope>INTERACTION WITH FKBP6</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>
Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-184; THR-211 AND SER-312
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>
Lysine acetylation targets protein complexes and co-regulates major cellular functions.
</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>
ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-61; LYS-194; LYS-219; LYS-227 AND LYS-254
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="Bioorg. Khim." volume="36" first="312" last="318">
<title>
Haponin (eIF1AD) interacts with glyceraldehyde 3-phosphate dehydrogenase in the CHO-K1 cell line.
</title>
<authorList>
<person name="Rakitina T.V."/>
<person name="Bogatova O.V."/>
<person name="Smirnova E.V."/>
<person name="Pozdeev V.I."/>
<person name="Kostanian I.A."/>
<person name="Lipkin V.M."/>
</authorList>
<dbReference type="PubMed" id="20644585"/>
<dbReference type="DOI" id="10.1134/s1068162010030027"/>
</citation>
<scope>INTERACTION WITH EIF1AD</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-75; SER-83 AND THR-184
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>
Initial characterization of the human central proteome.
</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Mol. Cell. Proteomics" volume="10" first="M111.012658.01" last="M111.012658.12">
<title>
The first identification of lysine malonylation substrates and its regulatory enzyme.
</title>
<authorList>
<person name="Peng C."/>
<person name="Lu Z."/>
<person name="Xie Z."/>
<person name="Cheng Z."/>
<person name="Chen Y."/>
<person name="Tan M."/>
<person name="Luo H."/>
<person name="Zhang Y."/>
<person name="He W."/>
<person name="Yang K."/>
<person name="Zwaans B.M."/>
<person name="Tishkoff D."/>
<person name="Ho L."/>
<person name="Lombard D."/>
<person name="He T.C."/>
<person name="Dai J."/>
<person name="Verdin E."/>
<person name="Ye Y."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="21908771"/>
<dbReference type="DOI" id="10.1074/mcp.m111.012658"/>
</citation>
<scope>MALONYLATION AT LYS-194 AND LYS-215</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>
System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="4733" last="4743">
<title>
Resveratrol-induced changes of the human adipocyte secretion profile.
</title>
<authorList>
<person name="Rosenow A."/>
<person name="Noben J.P."/>
<person name="Jocken J."/>
<person name="Kallendrusch S."/>
<person name="Fischer-Posovszky P."/>
<person name="Mariman E.C."/>
<person name="Renes J."/>
</authorList>
<dbReference type="PubMed" id="22905912"/>
<dbReference type="DOI" id="10.1021/pr300539b"/>
</citation>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Mol. Cell" volume="47" first="656" last="663">
<title>
Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation.
</title>
<authorList>
<person name="Jia J."/>
<person name="Arif A."/>
<person name="Willard B."/>
<person name="Smith J.D."/>
<person name="Stuehr D.J."/>
<person name="Hazen S.L."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="22771119"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.06.006"/>
</citation>
<scope>INTERACTION WITH RPL13A</scope>
<scope>S-NITROSYLATION AT CYS-247</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="5046" last="5055">
<title>
Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages.
</title>
<authorList>
<person name="Arif A."/>
<person name="Chatterjee P."/>
<person name="Moodt R.A."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="23071094"/>
<dbReference type="DOI" id="10.1128/mcb.01168-12"/>
</citation>
<scope>FUNCTION</scope>
<scope>RECONSTITUTION OF THE GAIT COMPLEX</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="Cell Host Microbe" volume="13" first="87" last="99">
<title>
NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation.
</title>
<authorList>
<person name="Gao X."/>
<person name="Wang X."/>
<person name="Pham T.H."/>
<person name="Feuerbacher L.A."/>
<person name="Lubos M.L."/>
<person name="Huang M."/>
<person name="Olsen R."/>
<person name="Mushegian A."/>
<person name="Slawson C."/>
<person name="Hardwidge P.R."/>
</authorList>
<dbReference type="PubMed" id="23332158"/>
<dbReference type="DOI" id="10.1016/j.chom.2012.11.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>GLYCOSYLATION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH TRAF2</scope>
<scope>
MUTAGENESIS OF CYS-152; THR-211; THR-229; SER-241; THR-246 AND THR-277
</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>
Toward a comprehensive characterization of a human cancer cell phosphoproteome.
</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-151; THR-153; THR-229 AND SER-333
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="Cell" volume="159" first="623" last="634">
<title>
Target-selective protein S-nitrosylation by sequence motif recognition.
</title>
<authorList>
<person name="Jia J."/>
<person name="Arif A."/>
<person name="Terenzi F."/>
<person name="Willard B."/>
<person name="Plow E.F."/>
<person name="Hazen S.L."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="25417112"/>
<dbReference type="DOI" id="10.1016/j.cell.2014.09.032"/>
</citation>
<scope>S-NITROSYLATION AT CYS-247</scope>
<scope>MUTAGENESIS OF LEU-245 AND GLU-250</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="26922" last="26936">
<title>
Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Samson A.L."/>
<person name="Knaupp A.S."/>
<person name="Kass I."/>
<person name="Kleifeld O."/>
<person name="Marijanovic E.M."/>
<person name="Hughes V.A."/>
<person name="Lupton C.J."/>
<person name="Buckle A.M."/>
<person name="Bottomley S.P."/>
<person name="Medcalf R.L."/>
</authorList>
<dbReference type="PubMed" id="25086035"/>
<dbReference type="DOI" id="10.1074/jbc.m114.570275"/>
</citation>
<scope>MECHANISM OF FREE RADICAL-INDUCED AGGREGATION</scope>
<scope>ACTIVE SITE</scope>
<scope>OXIDATION AT MET-46</scope>
<scope>
MUTAGENESIS OF MET-46; MET-105; CYS-152; CYS-156; TRP-196; CYS-247 AND TYR-320
</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-177; THR-182; THR-184 AND SER-241
</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>
N-terminome analysis of the human mitochondrial proteome.
</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2016" name="J. Biol. Chem." volume="291" first="18232" last="18238">
<title>
Citrobacter rodentium NleB protein inhibits tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) ubiquitination to reduce host type I interferon production.
</title>
<authorList>
<person name="Gao X."/>
<person name="Pham T.H."/>
<person name="Feuerbacher L.A."/>
<person name="Chen K."/>
<person name="Hays M.P."/>
<person name="Singh G."/>
<person name="Rueter C."/>
<person name="Hurtado-Guerrero R."/>
<person name="Hardwidge P.R."/>
</authorList>
<dbReference type="PubMed" id="27387501"/>
<dbReference type="DOI" id="10.1074/jbc.m116.738278"/>
</citation>
<scope>FUNCTION</scope>
<scope>GLYCOSYLATION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH TRAF2</scope>
<scope>MUTAGENESIS OF CYS-152</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2017" name="J. Biol. Chem." volume="292" first="11423" last="11430">
<title>
NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity.
</title>
<authorList>
<person name="El Qaidi S."/>
<person name="Chen K."/>
<person name="Halim A."/>
<person name="Siukstaite L."/>
<person name="Rueter C."/>
<person name="Hurtado-Guerrero R."/>
<person name="Clausen H."/>
<person name="Hardwidge P.R."/>
</authorList>
<dbReference type="PubMed" id="28522607"/>
<dbReference type="DOI" id="10.1074/jbc.m117.790675"/>
</citation>
<scope>
GLYCOSYLATION AT ARG-197 AND ARG-200 (MICROBIAL INFECTION)
</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>
Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-186</scope>
<scope>
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1976" name="J. Mol. Biol." volume="104" first="277" last="283">
<title>
Twinning in crystals of human skeletal muscle D-glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Mercer W.D."/>
<person name="Winn S.I."/>
<person name="Watson H.C."/>
</authorList>
<dbReference type="PubMed" id="957435"/>
<dbReference type="DOI" id="10.1016/0022-2836(76)90013-9"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS)</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2005" name="Acta Crystallogr. D" volume="61" first="1508" last="1513">
<title>
Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Ismail S.A."/>
<person name="Park H.W."/>
</authorList>
<dbReference type="PubMed" id="16239728"/>
<dbReference type="DOI" id="10.1107/s0907444905026740"/>
</citation>
<scope>
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH NAD
</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2006" name="Acta Crystallogr. D" volume="62" first="290" last="301">
<title>
High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase.
</title>
<authorList>
<person name="Jenkins J.L."/>
<person name="Tanner J.J."/>
</authorList>
<dbReference type="PubMed" id="16510976"/>
<dbReference type="DOI" id="10.1107/s0907444905042289"/>
</citation>
<scope>
X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH NAD
</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="1 6 19 20 23 25">
Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively (PubMed:3170585, PubMed:11724794). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate (PubMed:3170585, PubMed:11724794). Modulates the organization and assembly of the cytoskeleton (By similarity). Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes (PubMed:23071094). Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation (PubMed:23071094). Also plays a role in innate immunity by promoting TNF-induced NF-kappa-B activation and type I interferon production, via interaction with TRAF2 and TRAF3, respectively (PubMed:23332158, PubMed:27387501). Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis (By similarity). Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC (By similarity).
</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5 25">
<text>
D-glyceraldehyde 3-phosphate + NAD(+) + phosphate = (2R)-3-phospho-glyceroyl phosphate + H(+) + NADH
</text>
<dbReference type="Rhea" id="RHEA:10300"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57604"/>
<dbReference type="ChEBI" id="CHEBI:57945"/>
<dbReference type="ChEBI" id="CHEBI:59776"/>
<dbReference type="EC" id="1.2.1.12"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="1">
<text>
L-cysteinyl-[protein] + S-nitroso-L-cysteinyl-[GAPDH] = L-cysteinyl-[GAPDH] + S-nitroso-L-cysteinyl-[protein]
</text>
<dbReference type="Rhea" id="RHEA:66684"/>
<dbReference type="Rhea" id="RHEA-COMP:10131"/>
<dbReference type="Rhea" id="RHEA-COMP:17089"/>
<dbReference type="Rhea" id="RHEA-COMP:17090"/>
<dbReference type="Rhea" id="RHEA-COMP:17091"/>
<dbReference type="ChEBI" id="CHEBI:29950"/>
<dbReference type="ChEBI" id="CHEBI:149494"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="1">
<dbReference type="Rhea" id="RHEA:66685"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="1">
Glyceraldehyde-3-phosphate dehydrogenase activity is inhibited by fumarate, via the formation of S-(2-succinyl)cysteine residues.
</text>
</comment>
<comment type="pathway">
<text>
Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 1/5.
</text>
</comment>
<comment type="subunit">
<text evidence="1 2 6 9 10 11 12 13 15 16 18 20 23">
Homotetramer (PubMed:16239728, PubMed:16510976). Interacts with TPPP; the interaction is direct (By similarity). Interacts (when S-nitrosylated) with SIAH1; leading to nuclear translocation (By similarity). Interacts with RILPL1/GOSPEL, leading to prevent the interaction between GAPDH and SIAH1 and prevent nuclear translocation (By similarity). Interacts with CHP1; the interaction increases the binding of CHP1 with microtubules (By similarity). Associates with microtubules (By similarity). Interacts with EIF1AD, USP25, PRKCI and WARS1 (PubMed:11724794, PubMed:16501887, PubMed:15628863, PubMed:20644585). Interacts with phosphorylated RPL13A; inhibited by oxidatively-modified low-densitity lipoprotein (LDL(ox)) (PubMed:22771119). Component of the GAIT complex (PubMed:15479637). Interacts with FKBP6; leading to inhibit GAPDH catalytic activity (PubMed:19001379). Interacts with TRAF2, promoting TRAF2 ubiquitination (PubMed:23332158). Interacts with TRAF3, promoting TRAF3 ubiquitination (PubMed:27387501).
</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-10173507">
<id>Q6UY14-3</id>
<label>ADAMTSL4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-3916527">
<id>Q9UIJ7</id>
<label>AK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-77613">
<id>P05067</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-1383687">
<id>Q9UQM7</id>
<label>CAMK2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-473101">
<id>Q14194</id>
<label>CRMP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-19157435">
<id>Q9BPW9-4</id>
<label>DHRS9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-949824">
<id>O00471</id>
<label>EXOC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-744771">
<id>O75344</id>
<label>FKBP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-354056">
<id>P04406</id>
<label>GAPDH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-745707">
<id>Q8NEA9</id>
<label>GMCL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-20795332">
<id>Q92993-2</id>
<label>KAT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-722805">
<id>P42695</id>
<label>NCAPD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-6662224">
<id>P35228</id>
<label>NOS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-358311">
<id>P12004</id>
<label>PCNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-709599">
<id>P00558</id>
<label>PGK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-1049962">
<id>P48147</id>
<label>PREP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-476586">
<id>P17612</id>
<label>PRKACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-743880">
<id>Q8WUY3</id>
<label>PRUNE2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-11529177">
<id>Q9UHX1-2</id>
<label>PUF60</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-621404">
<id>P15927</id>
<label>RPA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-355281">
<id>P05109</id>
<label>S100A8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-7225508">
<id>Q96GZ6</id>
<label>SLC41A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-990792">
<id>P00441</id>
<label>SOD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-717399">
<id>Q9BSI4</id>
<label>TINF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354056">
<id>P04406</id>
</interactant>
<interactant intactId="EBI-594644">
<id>P10599</id>
<label>TXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
<location evidence="8">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
<location evidence="8">Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
<location evidence="1">Cytoskeleton</location>
</subcellularLocation>
<text evidence="1 8">
Translocates to the nucleus following S-nitrosylation and interaction with SIAH1, which contains a nuclear localization signal (By similarity). Postnuclear and Perinuclear regions (PubMed:12829261).
</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P04406-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04406-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047289"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="35">
The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex.
</text>
</comment>
<comment type="PTM">
<text evidence="1 18 22">
S-nitrosylation of Cys-152 leads to interaction with SIAH1, followed by translocation to the nucleus (By similarity). S-nitrosylation of Cys-247 is induced by interferon-gamma and LDL(ox) implicating the iNOS-S100A8/9 transnitrosylase complex and seems to prevent interaction with phosphorylated RPL13A and to interfere with GAIT complex activity (PubMed:22771119, PubMed:25417112).
</text>
</comment>
<comment type="PTM">
<text evidence="33">ISGylated.</text>
</comment>
<comment type="PTM">
<text evidence="3">
Sulfhydration at Cys-152 increases catalytic activity.
</text>
</comment>
<comment type="PTM">
<text evidence="34">
Oxidative stress can promote the formation of high molecular weight disulfide-linked GAPDH aggregates, through a process called nucleocytoplasmic coagulation. Such aggregates can be observed in vivo in the affected tissues of patients with Alzheimer disease or alcoholic liver cirrhosis, or in cell cultures during necrosis. Oxidation at Met-46 may play a pivotal role in the formation of these insoluble structures. This modification has been detected in vitro following treatment with free radical donor (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide. It has been proposed to destabilize nearby residues, increasing the likelihood of secondary oxidative damages, including oxidation of Tyr-45 and Met-105. This cascade of oxidations may augment GAPDH misfolding, leading to intermolecular disulfide cross-linking and aggregation.
</text>
</comment>
<comment type="PTM">
<text evidence="1">
Succination of Cys-152 and Cys-247 by the Krebs cycle intermediate fumarate, which leads to S-(2-succinyl)cysteine residues, inhibits glyceraldehyde-3-phosphate dehydrogenase activity. Fumarate concentration as well as succination of cysteine residues in GAPDH is significantly increased in muscle of diabetic mammals. It was proposed that the S-(2-succinyl)cysteine chemical modification may be a useful biomarker of mitochondrial and oxidative stress in diabetes and that succination of GAPDH and other thiol proteins by fumarate may contribute to the metabolic changes underlying the development of diabetes complications.
</text>
</comment>
<comment type="PTM">
<text evidence="20 23 24">
(Microbial infection) Glycosylated by C.rodentium protein NleB, enteropathogenic E.coli protein NleB1 and S.typhimurium protein Ssek1: arginine GlcNAcylation prevents the interaction with TRAF2 and TRAF3 (PubMed:23332158, PubMed:27387501, PubMed:28522607). This leads to reduced ubiquitination of TRAF2 and TRAF3, and subsequent inhibition of NF-kappa-B signaling and type I interferon production, respectively (PubMed:23332158, PubMed:27387501).
</text>
</comment>
<comment type="similarity">
<text evidence="30">
Belongs to the glyceraldehyde-3-phosphate dehydrogenase family.
</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/gapd/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Glyceraldehyde_3-phosphate_dehydrogenase"/>
<text>Glyceraldehyde 3-phosphate dehydrogenase entry</text>
</comment>
<dbReference type="EC" id="1.2.1.12" evidence="25"/>
<dbReference type="EC" id="2.6.99.-" evidence="1"/>
<dbReference type="EMBL" id="X01677">
<property type="protein sequence ID" value="CAA25833.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M17851">
<property type="protein sequence ID" value="AAA86283.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M33197">
<property type="protein sequence ID" value="AAA52518.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J02642">
<property type="protein sequence ID" value="AAA52496.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J04038">
<property type="protein sequence ID" value="AAA53191.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X53778">
<property type="protein sequence ID" value="CAA37794.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF261085">
<property type="protein sequence ID" value="AAF99678.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY007133">
<property type="protein sequence ID" value="AAG01996.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB062273">
<property type="protein sequence ID" value="BAB93466.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT006893">
<property type="protein sequence ID" value="AAP35539.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY340484">
<property type="protein sequence ID" value="AAP88932.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR407671">
<property type="protein sequence ID" value="CAG28599.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006064">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471116">
<property type="protein sequence ID" value="EAW88787.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001601">
<property type="protein sequence ID" value="AAH01601.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004109">
<property type="protein sequence ID" value="AAH04109.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009081">
<property type="protein sequence ID" value="AAH09081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013310">
<property type="protein sequence ID" value="AAH13310.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC023632">
<property type="protein sequence ID" value="AAH23632.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025925">
<property type="protein sequence ID" value="AAH25925.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC026907">
<property type="protein sequence ID" value="AAH26907.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC029618">
<property type="protein sequence ID" value="AAH29618.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC083511">
<property type="protein sequence ID" value="AAH83511.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58201.1">
<molecule id="P04406-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8549.1">
<molecule id="P04406-1"/>
</dbReference>
<dbReference type="PIR" id="A31988">
<property type="entry name" value="DEHUG3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243728.1">
<molecule id="P04406-2"/>
<property type="nucleotide sequence ID" value="NM_001256799.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276674.1">
<molecule id="P04406-1"/>
<property type="nucleotide sequence ID" value="NM_001289745.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276675.1">
<molecule id="P04406-1"/>
<property type="nucleotide sequence ID" value="NM_001289746.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002037.2">
<molecule id="P04406-1"/>
<property type="nucleotide sequence ID" value="NM_002046.5"/>
</dbReference>
<dbReference type="PDB" id="1U8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75 A"/>
<property type="chains" value="O/P/Q/R=1-335"/>
</dbReference>
<dbReference type="PDB" id="1ZNQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50 A"/>
<property type="chains" value="O/P/Q/R=1-335"/>
</dbReference>
<dbReference type="PDB" id="3GPD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50 A"/>
<property type="chains" value="G/R=2-335"/>
</dbReference>
<dbReference type="PDB" id="4WNC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99 A"/>
<property type="chains" value="A/B/C/D/E/F/G/O=1-335"/>
</dbReference>
<dbReference type="PDB" id="4WNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30 A"/>
<property type="chains" value="A/B/C/O=1-335"/>
</dbReference>
<dbReference type="PDB" id="6ADE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15 A"/>
<property type="chains" value="A/B/C=1-335"/>
</dbReference>
<dbReference type="PDB" id="6IQ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29 A"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-335"/>
</dbReference>
<dbReference type="PDB" id="6M61">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82 A"/>
<property type="chains" value="O/P/Q/R=1-335"/>
</dbReference>
<dbReference type="PDB" id="6YND">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52 A"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-335"/>
</dbReference>
<dbReference type="PDB" id="6YNE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85 A"/>
<property type="chains" value="A/B/C/D=1-335"/>
</dbReference>
<dbReference type="PDB" id="6YNF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39 A"/>
<property type="chains" value="A/B/C/D/E/F/G/H=2-335"/>
</dbReference>
<dbReference type="PDB" id="6YNH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62 A"/>
<property type="chains" value="B/D/F/G=1-335"/>
</dbReference>
<dbReference type="PDB" id="8DNS">
<property type="method" value="EM"/>
<property type="resolution" value="3.22 A"/>
<property type="chains" value="O/P/Q/R=1-335"/>
</dbReference>
<dbReference type="PDBsum" id="1U8F"/>
<dbReference type="PDBsum" id="1ZNQ"/>
<dbReference type="PDBsum" id="3GPD"/>
<dbReference type="PDBsum" id="4WNC"/>
<dbReference type="PDBsum" id="4WNI"/>
<dbReference type="PDBsum" id="6ADE"/>
<dbReference type="PDBsum" id="6IQ6"/>
<dbReference type="PDBsum" id="6M61"/>
<dbReference type="PDBsum" id="6YND"/>
<dbReference type="PDBsum" id="6YNE"/>
<dbReference type="PDBsum" id="6YNF"/>
<dbReference type="PDBsum" id="6YNH"/>
<dbReference type="PDBsum" id="8DNS"/>
<dbReference type="AlphaFoldDB" id="P04406"/>
<dbReference type="SMR" id="P04406"/>
<dbReference type="BioGRID" id="108868">
<property type="interactions" value="505"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2476">
<property type="entry name" value="GAIT complex"/>
</dbReference>
<dbReference type="CORUM" id="P04406"/>
<dbReference type="DIP" id="DIP-32521N"/>
<dbReference type="IntAct" id="P04406">
<property type="interactions" value="215"/>
</dbReference>
<dbReference type="MINT" id="P04406"/>
<dbReference type="STRING" id="9606.ENSP00000229239"/>
<dbReference type="BindingDB" id="P04406"/>
<dbReference type="ChEMBL" id="CHEMBL2284"/>
<dbReference type="DrugBank" id="DB07347">
<property type="generic name" value="4-(2-Aminoethyl)Benzenesulfonyl Fluoride"/>
</dbReference>
<dbReference type="DrugBank" id="DB02059">
<property type="generic name" value="Adenosine-5-Diphosphoribose"/>
</dbReference>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB09130">
<property type="generic name" value="Copper"/>
</dbReference>
<dbReference type="DrugBank" id="DB00157">
<property type="generic name" value="NADH"/>
</dbReference>
<dbReference type="DrugBank" id="DB03893">
<property type="generic name" value="Thionicotinamide-Adenine-Dinucleotide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09092">
<property type="generic name" value="Xanthinol"/>
</dbReference>
<dbReference type="DrugCentral" id="P04406"/>
<dbReference type="MoonDB" id="P04406">
<property type="type" value="Curated"/>
</dbReference>
<dbReference type="MoonProt" id="P04406"/>
<dbReference type="GlyConnect" id="1941">
<property type="glycosylation" value="7 N-Linked glycans (2 sites)"/>
</dbReference>
<dbReference type="GlyCosmos" id="P04406">
<property type="glycosylation" value="6 sites, 9 glycans"/>
</dbReference>
<dbReference type="GlyGen" id="P04406">
<property type="glycosylation" value="4 sites, 7 N-linked glycans (2 sites), 2 O-linked glycans (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P04406"/>
<dbReference type="MetOSite" id="P04406"/>
<dbReference type="PhosphoSitePlus" id="P04406"/>
<dbReference type="SwissPalm" id="P04406"/>
<dbReference type="BioMuta" id="GAPDH"/>
<dbReference type="DMDM" id="120649"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P04406"/>
<dbReference type="OGP" id="P04406"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00219018"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P04406"/>
<dbReference type="SWISS-2DPAGE" id="P04406"/>
<dbReference type="UCD-2DPAGE" id="P04406"/>
<dbReference type="CPTAC" id="CPTAC-2733"/>
<dbReference type="CPTAC" id="CPTAC-5855"/>
<dbReference type="CPTAC" id="CPTAC-5880"/>
<dbReference type="CPTAC" id="CPTAC-5942"/>
<dbReference type="EPD" id="P04406"/>
<dbReference type="jPOST" id="P04406"/>
<dbReference type="MassIVE" id="P04406"/>
<dbReference type="MaxQB" id="P04406"/>
<dbReference type="PaxDb" id="P04406"/>
<dbReference type="PeptideAtlas" id="P04406"/>
<dbReference type="PRIDE" id="P04406"/>
<dbReference type="ProteomicsDB" id="18491"/>
<dbReference type="ProteomicsDB" id="51703">
<molecule id="P04406-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P04406-1">
<molecule id="P04406-1"/>
</dbReference>
<dbReference type="ABCD" id="P04406">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="3923">
<property type="antibodies" value="2829 antibodies from 59 providers"/>
</dbReference>
<dbReference type="CPTC" id="P04406">
<property type="antibodies" value="1 antibody"/>
</dbReference>
<dbReference type="DNASU" id="2597"/>
<dbReference type="Ensembl" id="ENST00000229239.10">
<molecule id="P04406-1"/>
<property type="protein sequence ID" value="ENSP00000229239.5"/>
<property type="gene ID" value="ENSG00000111640.15"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396858.5">
<molecule id="P04406-2"/>
<property type="protein sequence ID" value="ENSP00000380067.1"/>
<property type="gene ID" value="ENSG00000111640.15"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396859.5">
<molecule id="P04406-1"/>
<property type="protein sequence ID" value="ENSP00000380068.1"/>
<property type="gene ID" value="ENSG00000111640.15"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396861.5">
<molecule id="P04406-1"/>
<property type="protein sequence ID" value="ENSP00000380070.1"/>
<property type="gene ID" value="ENSG00000111640.15"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000619601.1">
<molecule id="P04406-2"/>
<property type="protein sequence ID" value="ENSP00000478864.1"/>
<property type="gene ID" value="ENSG00000111640.15"/>
</dbReference>
<dbReference type="GeneID" id="2597"/>
<dbReference type="KEGG" id="hsa:2597"/>
<dbReference type="MANE-Select" id="ENST00000229239.10">
<property type="protein sequence ID" value="ENSP00000229239.5"/>
<property type="RefSeq nucleotide sequence ID" value="NM_002046.7"/>
<property type="RefSeq protein sequence ID" value="NP_002037.2"/>
</dbReference>
<dbReference type="UCSC" id="uc031qfw.3">
<molecule id="P04406-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="AGR" id="HGNC:4141"/>
<dbReference type="CTD" id="2597"/>
<dbReference type="DisGeNET" id="2597"/>
<dbReference type="GeneCards" id="GAPDH"/>
<dbReference type="HGNC" id="HGNC:4141">
<property type="gene designation" value="GAPDH"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000111640">
<property type="expression patterns" value="Group enriched (skeletal muscle, tongue)"/>
</dbReference>
<dbReference type="MalaCards" id="GAPDH"/>
<dbReference type="MIM" id="138400">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04406"/>
<dbReference type="OpenTargets" id="ENSG00000111640"/>
<dbReference type="PharmGKB" id="PA28554"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000111640"/>
<dbReference type="eggNOG" id="KOG0657">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153298"/>
<dbReference type="HOGENOM" id="CLU_030140_0_3_1"/>
<dbReference type="InParanoid" id="P04406"/>
<dbReference type="OMA" id="TCRIEKG"/>
<dbReference type="OrthoDB" id="275384at2759"/>
<dbReference type="PhylomeDB" id="P04406"/>
<dbReference type="TreeFam" id="TF300533"/>
<dbReference type="BioCyc" id="MetaCyc:HS03433-MON"/>
<dbReference type="BRENDA" id="1.2.1.12">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P04406"/>
<dbReference type="Reactome" id="R-HSA-70171">
<property type="pathway name" value="Glycolysis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-70263">
<property type="pathway name" value="Gluconeogenesis"/>
</dbReference>
<dbReference type="SABIO-RK" id="P04406"/>
<dbReference type="SignaLink" id="P04406"/>
<dbReference type="SIGNOR" id="P04406"/>
<dbReference type="UniPathway" id="UPA00109">
<property type="reaction ID" value="UER00184"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="2597">
<property type="hits" value="626 hits in 1149 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GAPDH">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04406"/>
<dbReference type="GeneWiki" id="Glyceraldehyde_3-phosphate_dehydrogenase"/>
<dbReference type="GenomeRNAi" id="2597"/>
<dbReference type="Pharos" id="P04406">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P04406"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P04406">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111640">
<property type="expression patterns" value="Expressed in frontal pole and 216 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P04406">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04406">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097452">
<property type="term" value="C:GAIT complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019828">
<property type="term" value="F:aspartic-type endopeptidase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004365">
<property type="term" value="F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051287">
<property type="term" value="F:NAD binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0050661">
<property type="term" value="F:NADP binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0035605">
<property type="term" value="F:peptidyl-cysteine S-nitrosylase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061844">
<property type="term" value="P:antimicrobial humoral immune response mediated by antimicrobial peptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to type II interferon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050832">
<property type="term" value="P:defense response to fungus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006006">
<property type="term" value="P:glucose metabolic process"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006096">
<property type="term" value="P:glycolytic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051873">
<property type="term" value="P:killing by host of symbiont cells"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031640">
<property type="term" value="P:killing of cells of another organism"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000226">
<property type="term" value="P:microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010951">
<property type="term" value="P:negative regulation of endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051402">
<property type="term" value="P:neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035606">
<property type="term" value="P:peptidyl-cysteine S-trans-nitrosylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001819">
<property type="term" value="P:positive regulation of cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016241">
<property type="term" value="P:regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.720">
<property type="entry name" value="NAD(P)-binding Rossmann-like Domain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020831">
<property type="entry name" value="GlycerAld/Erythrose_P_DH"/>
</dbReference>
<dbReference type="InterPro" id="IPR020830">
<property type="entry name" value="GlycerAld_3-P_DH_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020829">
<property type="entry name" value="GlycerAld_3-P_DH_cat"/>
</dbReference>
<dbReference type="InterPro" id="IPR020828">
<property type="entry name" value="GlycerAld_3-P_DH_NAD(P)-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR006424">
<property type="entry name" value="Glyceraldehyde-3-P_DH_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10836">
<property type="entry name" value="GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10836:SF111">
<property type="entry name" value="GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02800">
<property type="entry name" value="Gp_dh_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00044">
<property type="entry name" value="Gp_dh_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000149">
<property type="entry name" value="GAP_DH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00078">
<property type="entry name" value="G3PDHDRGNASE"/>
</dbReference>
<dbReference type="SMART" id="SM00846">
<property type="entry name" value="Gp_dh_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55347">
<property type="entry name" value="Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="NAD(P)-binding Rossmann-fold domains"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01534">
<property type="entry name" value="GAPDH-I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00071">
<property type="entry name" value="GAPDH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0324">Glycolysis</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0558">Oxidation</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="7 27">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" id="PRO_0000145486" description="Glyceraldehyde-3-phosphate dehydrogenase">
<location>
<begin position="2"/>
<end position="335"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with WARS1" evidence="10">
<location>
<begin position="2"/>
<end position="148"/>
</location>
</feature>
<feature type="short sequence motif" description="[IL]-x-C-x-x-[DE] motif" evidence="35">
<location>
<begin position="245"/>
<end position="250"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="21">
<location>
<position position="152"/>
</location>
</feature>
<feature type="binding site" evidence="11 13">
<location>
<begin position="13"/>
<end position="14"/>
</location>
<ligand>
<name>NAD(+)</name>
<dbReference type="ChEBI" id="CHEBI:57540"/>
</ligand>
</feature>
<feature type="binding site" evidence="11 13">
<location>
<position position="35"/>
</location>
<ligand>
<name>NAD(+)</name>
<dbReference type="ChEBI" id="CHEBI:57540"/>
</ligand>
</feature>
<feature type="binding site" evidence="11 13">
<location>
<position position="80"/>
</location>
<ligand>
<name>NAD(+)</name>
<dbReference type="ChEBI" id="CHEBI:57540"/>
</ligand>
</feature>
<feature type="binding site" evidence="11 13">
<location>
<position position="122"/>
</location>
<ligand>
<name>NAD(+)</name>
<dbReference type="ChEBI" id="CHEBI:57540"/>
</ligand>
</feature>
<feature type="binding site" evidence="4">
<location>
<begin position="151"/>
<end position="153"/>
</location>
<ligand>
<name>D-glyceraldehyde 3-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:59776"/>
</ligand>
</feature>
<feature type="binding site" evidence="4">
<location>
<position position="182"/>
</location>
<ligand>
<name>D-glyceraldehyde 3-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:59776"/>
</ligand>
</feature>
<feature type="binding site" evidence="4">
<location>
<begin position="211"/>
<end position="212"/>
</location>
<ligand>
<name>D-glyceraldehyde 3-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:59776"/>
</ligand>
</feature>
<feature type="binding site" evidence="4">
<location>
<position position="234"/>
</location>
<ligand>
<name>D-glyceraldehyde 3-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:59776"/>
</ligand>
</feature>
<feature type="binding site" evidence="11 13">
<location>
<position position="316"/>
</location>
<ligand>
<name>NAD(+)</name>
<dbReference type="ChEBI" id="CHEBI:57540"/>
</ligand>
</feature>
<feature type="site" description="Activates thiol group during catalysis" evidence="31 32">
<location>
<position position="179"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylglycine" evidence="14">
	<location>
		<position position="2"/>
	</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="14">
<location>
<position position="5"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="37">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Methionine sulfoxide; in vitro" evidence="34">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="40">
<location>
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="14">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14 42">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38 39 42 43 44">
<location>
<position position="83"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="122"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="148"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="149"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="39 44">
<location>
<position position="151"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosylcysteine; by autocatalysis; in irreversibly inhibited form" evidence="1">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Cysteine persulfide" evidence="3">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="1">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine; in reversibly inhibited form" evidence="1">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="44">
<location>
<position position="153"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="155"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="45">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="45">
<location>
<position position="182"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="39 41 42 45">
<location>
<position position="184"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="14">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="40">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="17">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="41">
<location>
<position position="211"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="14">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="17">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="40">
<location>
<position position="219"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="14">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="40">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14 44">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="45">
<location>
<position position="241"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="1">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="18 22">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="40">
<location>
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="14">
<location>
<position position="260"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="14">
<location>
<position position="263"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 41">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Deamidated asparagine" evidence="14">
<location>
<position position="316"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="44">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="14">
<location>
<position position="334"/>
</location>
</feature>
<feature type="modified residue" description="5-glutamyl 2-aminoadipic acid" evidence="14">
	<location>
		<position position="335"/>
	</location>
</feature>
<feature type="glycosylation site" description="(Microbial infection) N-beta-linked (GlcNAc) arginine" evidence="24">
<location>
<position position="197"/>
</location>
</feature>
<feature type="glycosylation site" description="(Microbial infection) N-beta-linked (GlcNAc) arginine" evidence="24">
<location>
<position position="200"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="46">
<location>
<position position="186"/>
</location>
</feature>
<feature type="splice variant" id="VSP_047289" description="In isoform 2." evidence="30">
<location>
<begin position="1"/>
<end position="42"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_018889" description="In dbSNP:rs45541435." evidence="26">
<original>A</original>
<variation>G</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_049218" description="In dbSNP:rs1062429.">
<original>K</original>
<variation>N</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="Drastic reduction of the extent and significant prolongation of the lag phase of free radical-induced aggregation." evidence="21">
<original>M</original>
<variation>L</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased resistance to free radical-induced aggregation." evidence="21">
<original>M</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly reduced glycolytic activity; when associated with S-156 and S-247. Forms free radical-induced aggregates, but to a lesser extent than wild-type protein; when associated with S-156 and S-247. Abolished interaction with TRAF2 and TRAF3." evidence="20 21 23">
<original>C</original>
<variation>S</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly reduced glycolytic activity; when associated with S-152 and S-247. Forms free radical-induced aggregates, but to a lesser extent than wild-type protein; when associated with S-156 and S-247." evidence="21">
<original>C</original>
<variation>S</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased free radical-induced aggregation." evidence="21">
<original>W</original>
<variation>F</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect glycosylation by C.rodentium protein NleB." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect glycosylation by C.rodentium protein NleB." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect glycosylation by C.rodentium protein NleB." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits S-nitrosylation of Cys-247; when associated with M-250." evidence="22">
<original>L</original>
<variation>M</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect glycosylation by C.rodentium protein NleB." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly reduced glycolytic activity; when associated with S-152 and S-156. Forms free radical-induced aggregates, but to a lesser extent than wild-type protein; when associated with S-156 and S-247." evidence="21">
<original>C</original>
<variation>S</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits S-nitrosylation of Cys-247; when associated with M-245." evidence="22">
<original>E</original>
<variation>M</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect glycosylation by C.rodentium protein NleB." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on free radical-induced aggregation." evidence="21">
<original>Y</original>
<variation>F</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA25833." evidence="30" ref="2">
<original>N</original>
<variation>D</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="5"/>
<end position="9"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="13"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="27"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="40"/>
<end position="48"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="51"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="66"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="105"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="110"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="117"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="152"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="170"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="185"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="207"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="213"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="227"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="241"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="255"/>
<end position="267"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="268"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="283"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="292"/>
<end position="296"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="297"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="301"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="307"/>
<end position="314"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="318"/>
<end position="333"/>
</location>
</feature>
<evidence type="ECO:0000250" key="1">
<source>
<dbReference type="UniProtKB" id="P04797"/>
</source>
</evidence>
<evidence type="ECO:0000250" key="2">
<source>
<dbReference type="UniProtKB" id="P10096"/>
</source>
</evidence>
<evidence type="ECO:0000250" key="3">
<source>
<dbReference type="UniProtKB" id="P16858"/>
</source>
</evidence>
<evidence type="ECO:0000250" key="4">
<source>
<dbReference type="UniProtKB" id="P22513"/>
</source>
</evidence>
<evidence type="ECO:0000255" key="5">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10009"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="6">
<source>
<dbReference type="PubMed" id="11724794"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="7">
<source>
<dbReference type="PubMed" id="12665801"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="8">
<source>
<dbReference type="PubMed" id="12829261"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="9">
<source>
<dbReference type="PubMed" id="15479637"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="10">
<source>
<dbReference type="PubMed" id="15628863"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="11">
<source>
<dbReference type="PubMed" id="16239728"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="12">
<source>
<dbReference type="PubMed" id="16501887"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="13">
<source>
<dbReference type="PubMed" id="16510976"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="14">
<source>
<dbReference type="PubMed" id="18183946"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="15">
<source>
<dbReference type="PubMed" id="19001379"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="16">
<source>
<dbReference type="PubMed" id="20644585"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="17">
<source>
<dbReference type="PubMed" id="21908771"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="18">
<source>
<dbReference type="PubMed" id="22771119"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="19">
<source>
<dbReference type="PubMed" id="23071094"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="20">
<source>
<dbReference type="PubMed" id="23332158"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="21">
<source>
<dbReference type="PubMed" id="25086035"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="22">
<source>
<dbReference type="PubMed" id="25417112"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="23">
<source>
<dbReference type="PubMed" id="27387501"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="24">
<source>
<dbReference type="PubMed" id="28522607"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="25">
<source>
<dbReference type="PubMed" id="3170585"/>
</source>
</evidence>
<evidence type="ECO:0000269" key="26">
<source ref="12"/>
</evidence>
<evidence type="ECO:0000269" key="27">
<source ref="19"/>
</evidence>
<evidence type="ECO:0000303" key="28">
<source>
<dbReference type="PubMed" id="2987855"/>
</source>
</evidence>
<evidence type="ECO:0000303" key="29">
<source>
<dbReference type="PubMed" id="6096136"/>
</source>
</evidence>
<evidence type="ECO:0000305" key="30"/>
<evidence type="ECO:0000305" key="31">
<source>
<dbReference type="PubMed" id="16239728"/>
</source>
</evidence>
<evidence type="ECO:0000305" key="32">
<source>
<dbReference type="PubMed" id="16510976"/>
</source>
</evidence>
<evidence type="ECO:0000305" key="33">
<source>
<dbReference type="PubMed" id="16815975"/>
</source>
</evidence>
<evidence type="ECO:0000305" key="34">
<source>
<dbReference type="PubMed" id="25086035"/>
</source>
</evidence>
<evidence type="ECO:0000305" key="35">
<source>
<dbReference type="PubMed" id="25417112"/>
</source>
</evidence>
<evidence type="ECO:0000312" key="36">
<source>
<dbReference type="HGNC" id="HGNC:4141"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="37">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="38">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="39">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="40">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="41">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="42">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="43">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="44">
<source>
</source>
</evidence>
<evidence type="ECO:0007744" key="45">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence type="ECO:0007744" key="46">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence type="ECO:0007829" key="47">
<source>
<dbReference type="PDB" id="6YND"/>
</source>
</evidence>
<sequence length="335" mass="36053" checksum="C9C135E8AE3E8744" modified="2007-01-23" version="3">
MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>